Clinical Trial Update: Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PET-guided (PET-adapted) chemotherapy strategies in patients with advanced Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Ospedale Santa Croce-Carle Cuneo | Conditions: HODGKIN LYMPHOMA | Phase 2 | Status: UNKNOWN